Quick Answer
Invivyd, Inc. reported Research And Development Expense of $38.31 million for the year ending 2025.
- Invivyd, Inc. showed a decrease of -72.1% in Research And Development Expense from 2024 to 2025.
- This data is from Invivyd, Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2020: $48.0 thousand | Q3 2020: $7.25 million | Q1 2021: $34.03 million | Q2 2021: $35.07 million | Q3 2021: $45.37 million | Q1 2022: $92.04 million | Q2 2022: $37.13 million | Q3 2022: $30.13 million | Q1 2023: $27.20 million | Q2 2023: $43.62 million | Q3 2023: $25.57 million | Q1 2024: $31.16 million | Q2 2024: $30.33 million | Q3 2024: $57.85 million | Q1 2025: $10.64 million | Q2 2025: $9.57 million | Q3 2025: $8.05 million.
- Over the full 5 years of available data (2021 to 2025), Invivyd, Inc.'s Research And Development Expense has declined by 79.1%.
- Historical annual values: Fiscal year 2025: $38.31 million | Fiscal year 2024: $137.25 million | Fiscal year 2023: $158.66 million | Fiscal year 2022: $179.21 million | Fiscal year 2021: $182.89 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: